POLAREAN IMAGING PLC
Offers a Xenon gas drug-device for non-invasive, radiation-free MRI of lung function.
POLX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BF3DT583
- LEI:
- 213800DGR2BHXJ36OL37
- Country:
- United States of America
- Address:
- 2500 MERIDIAN PARKWAY, 27713 DURHAM
- Website:
- https://polarean.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Polarean Imaging PLC is a medical imaging technology company specializing in the development and commercialization of a proprietary drug-device combination to revolutionize pulmonary medicine. The company's core platform utilizes hyperpolarized Xenon Xe 129 Gas Blend with Magnetic Resonance Imaging (MRI) to provide a non-invasive, radiation-free method for visualizing lung function and ventilation. This technology allows for a direct, regional measurement of lung function during a single, brief breath-hold. Polarean's system, which includes the gas blend and associated hardware like the HPX Hyperpolarizer, is designed to improve the diagnosis and management of chronic lung diseases such as COPD, asthma, and pulmonary fibrosis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 08:20 |
Delisting Announcement
Proposed Cancellation of Admission & Notice of GM
|
English | 91.5 KB | ||
| 2025-10-22 08:00 |
Delisting Announcement
Strategic review and consideration of AIM listing
|
English | 16.9 KB | ||
| 2025-09-29 08:00 |
Regulatory News Service
University of Virginia Health Hospital agreement
|
English | 21.9 KB | ||
| 2025-09-16 08:00 |
Report Publication Announcement
Notice of Results
|
English | 14.3 KB | ||
| 2025-09-11 17:36 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.1 KB | ||
| 2025-08-12 08:00 |
Legal Proceedings Report
Submission of new Phase III study protocol to FDA
|
English | 20.5 KB | ||
| 2025-07-24 08:00 |
Remuneration Information
Block Listing Six Monthly Return
|
English | 22.2 KB | ||
| 2025-06-24 08:00 |
Related Party Transaction
Promotion & sales representative agreement
|
English | 20.2 KB | ||
| 2025-06-02 08:00 |
Regulatory News Service
FDA expands XENOVIEW indication
|
English | 21.0 KB | ||
| 2025-05-15 13:48 |
Regulatory News Service
Xenon MRI featured prominently at ATS 2025
|
English | 51.6 KB | ||
| 2025-05-14 15:25 |
Environmental & Social Information
Ongoing collaboration with Philips
|
English | 13.0 KB | ||
| 2025-03-10 08:00 |
Regulatory News Service
Expansion of Xenon MRI imaging platform
|
English | 22.6 KB | ||
| 2025-02-27 08:00 |
Earnings Release
FY24 trading update
|
English | 20.3 KB | ||
| 2025-02-19 08:00 |
Regulatory News Service
Virtual Investor Day
|
English | 19.5 KB | ||
| 2025-02-03 08:00 |
M&A Activity
Taiwanese distributor agreement with Sumtage
|
English | 18.7 KB |
Automate Your Workflow. Get a real-time feed of all POLAREAN IMAGING PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for POLAREAN IMAGING PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for POLAREAN IMAGING PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
